Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : PSUN A new breakout at $30+! -- Ignore unavailable to you. Want to Upgrade?

To: E. Graphs who wrote (494)	6/3/1998 8:11:00 AM
From: Byelow	Read Replies (1) \| Respond to of 1622

E! I Think you'll be glad you did! THRX usually wallows in the second quarter until a late June or early July breakout. Last year it broke out around 6/21 about $22-23 and moved up to the $60 area before the split. BTW these are rough dates and prices from memory. I'm going to the annual meeting next week in Atlanta and will bring back a report. There is an active SI:THRX board as well as an active one on Yahoo. This is a favorite of mine and I believe they have a great future. The company has a proven track record and a good following by the MM and large funds. BTW I also own a very small position in NASI ( a THRX wannabe competitor). NASI is moving forward very fast to production of a Io-125 seed and hope to be in the Pd-103 game soon. I think their cheerleaders are a little too optomistic at this point but I have hopes that the cardiac stent/isotope solution they are currently developing can propel them into a major player outside the brachytherapy market. I don't expect that THRX (Pd-103) or Amersham (Io-125), the major players, are going to roll over and play dead while NASI takes away all their markets. THRX's announcement yesterday about the European approval is evidence of that and brings the importance of the J&J relationship to bear. Good luck in all your plays! Byelow